Welcome to the e-CCO Library!

P0683: Is it time to move away from malnutrition screening as a gateway to a dietitian referral in patients with Inflammatory Bowel Disease? An investigation into nutritional Issues in Crohn’s Disease Remission
Year: 2025
Source: ECCO'25
Authors: Westobyx7x7x7 C.(1)*;Katarachia x7x7x7 V.(1);McDonnellx7x7x7 M.(2);Sartainx7x7x7 S.(2);Cummings x7x7x7 J.R.F.(2);Wootton x7x7x7 S.(3);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0684: Real world experience with granulocyte and monocyte adsorptive apheresis (ADACOLUMN®) in patients with refractory inflammatory bowel disease: a retrospective observational multicenter cohort study
Year: 2025
Source: ECCO'25
Authors: Hupéx7x7x7 M.(1);Bouguenx7x7x7 G.(2);Buissonx7x7x7 A.(3);Landmanx7x7x7 C.(4);Uzzanx7x7x7 M.(5);Nanceyx7x7x7 S.(6);Guillaumex7x7x7 C.(7);Cyriellex7x7x7 G.(8);Charkaouix7x7x7 M.(9);Serrerox7x7x7 M.(10);Wampachx7x7x7 A.(11);Collinsx7x7x7 M.(12);Altweggx7x7x7 R.(13);Choletx7x7x7 F.(14);Amiotx7x7x7 A.(15)*;
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0685: Endoscopic severity at presentation and C-reactive protein predict immediate and twelve-month outcomes of second-line medical therapy in Acute Severe Ulcerative Colitis
Year: 2025
Source: ECCO'25
Authors: Subhaharanx7x7x7 D.(1)*;Kakkadasam Ramaswamy x7x7x7 P.(1);Edwardsx7x7x7 J.(1);Whitex7x7x7 L.(2);Patrickx7x7x7 D.(2);Shahzadx7x7x7 A.(3);Willmannx7x7x7 L.(1);Moattarx7x7x7 H.(1);Shuklax7x7x7 D.(1);Ishaqx7x7x7 N.(1);Bhullarx7x7x7 M.(1);Dorringtonx7x7x7 A.(1);Satsangix7x7x7 J.(4);Mohsenx7x7x7 W.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0686: Steroid use in patients with inflammatory bowel disease – claims data indicate a decline in steroid use for the first time over a five-year observation period in Germany
Year: 2025
Source: ECCO'25
Authors: Bokemeyerx7x7x7 B.(1)*;Stratilx7x7x7 A.S.(2);Friedrichx7x7x7 B.(2);Brunnerx7x7x7 P.(2);Rathx7x7x7 S.(3);Papukchievax7x7x7 S.(2);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0687: Development and validation of a novel multimodal model based on histology of colonoscopic biopsy to predict primary non-response to infliximab in patients with Crohn's disease
Year: 2025
Source: ECCO'25
Authors: Wangx7x7x7 Y.(1)*;Wangx7x7x7 H.(2);Yex7x7x7 Z.(3);Huangx7x7x7 B.(2);Maox7x7x7 R.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0688: Decisional conflict among patients with fistulizing perianal disease phenotype of Crohn’s disease at diagnosis
Year: 2025
Source: ECCO'25
Authors: Ibrahimx7x7x7 F.A.E.(1)*;Sebastianx7x7x7 S.(2);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0689: A clinical study on the optimization of vedolizumab induction therapy for moderate to severe active Ulcerative Colitis at week 10
Year: 2025
Source: ECCO'25
Authors: Lix7x7x7 M.(1)*;
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P068: Aberrant brain function in active-stage ulcerative colitis patients: a resting-state functional MRI study
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

W. Fan*1, S. Zhang1, J. Hu1, B. Liu1, L. Wen1, M. Gong1, G. Wang1, L. Yang2, Y. Chen2, H. Chen2, H. Guo2, D. Zhang1

Created: Friday, 22 February 2019, 9:41 AM
P068: Anti-fibrotic therapy for Crohn’s disease: in-vitro proof of concept with a selective ROCK2 inhibitor, LYC-53976, in the treatment of human intestinal myofibroblasts in stiffness and transforming growth factor β models
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

E. Rodansky1, X. Liu2, L. A. Johnson1, K. Demock2, A. J. Celeste2, L. L. Carter2, P. D. R. Higgins*1

Created: Friday, 22 February 2019, 9:49 AM
P068: Discovery of IBD3540: A Novel Gut-Restricted Glutamate Carboxypeptidase II Inhibitor with Preclinical Anti-Colitis Activity
Year: 2022
Source: ECCO'22
Authors: Peters, D.(1);Norris, L.(2);Tenora, L.(3);Snajdr, I.(3);Zhu, X.(4);Sakamoto, S.(4);Veeravalli, V.(2);Thomas, A.(2);Majer, P.(3);Rais, R.(2);Slusher, B.(2);
Created: Friday, 11 February 2022, 3:52 PM
P068: Evaluation of the therapeutic potential of metformin-pretreated tonsil-derived mesenchymal stem cells in a chronic colitis model
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Lee K.E.*1, Jung S.-A.1, Joo Y.-H.1, Tae C.H.1, Moon C.M.1, Kim S.-E.1, Jung H.-K.1, Shim K.-N.1, Yoo K.1, Yu Y.s.2, Jo I.h.2

Created: Wednesday, 20 February 2019, 10:36 AM
P068: Loss of PTPN22 abrogates the beneficial effect of faecal microbiota transfer
Year: 2018
Source: ECCO '18 Vienna
Authors:

M. Spalinger*, M. Schwarzfischer, C. Gottier, L. Hering, S. Lang, G. Rogler, M. Scharl

Created: Thursday, 21 February 2019, 9:14 AM
P068: Polyunsaturated fatty acid excess fuels pro-inflammatory transcriptional networks in GPX4 deficient intestinal epithelial cells
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Meyer, M.(1)*;Grabherr, F.(1);Schwärzler, J.(1);Mayr, L.(1);Jukic, A.(1);Rao, Z.(2);Rieder, D.(3);Zollner, A.(1);Grander, C.(1);Trajanoski, Z.(3);Koeberle, A.(2);Tilg, H.(1);Adolph, T.E.(1);
Created: Friday, 14 July 2023, 10:48 AM
P068: The combination of JAK1 and TPL2 or IRAK4 inhibitors is more effective than single agents in reducing TLR-mediated cytokine responses in human monocyte populations
Year: 2021
Source: ECCO'21 Virtual
Authors: Hornsby, E.(1);Yadon, A.N.(2);Clarke, A.(2);Grant, E.(3);Lindsay, J.O.(1);Stagg, A.J.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P069 CD73 promotes colitis-associated tumourigenesis in mice
Year: 2020
Source:

ECCO'20 Vienna

Authors:

X. Wu, X. Liu, N. Lan, X. Zheng, Y. Chen, Z. Cai, P. Lan, X. Wu

Created: Thursday, 30 January 2020, 10:12 AM
P0690: Purposeful design and integration of a pilot Inflammatory Bowel Disease (IBD) diet clinic into a multi-disciplinary IBD service demonstrates exemplar service utility and is of high value to patients
Year: 2025
Source: ECCO'25
Authors: Dayx7x7x7 A.(1x7x7x72x7x7x73)*;Chux7x7x7 M.(1x7x7x74);Scintox7x7x7 T.(3);Hanx7x7x7 S.(1);Vincix7x7x7 I.(1);Hatzix7x7x7 M.(3);Bryantx7x7x7 R.(1x7x7x72);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0691: Impact of Ozanimod (OZA) on Circulating Neutrophils: Results from the Phase 3 Japanese True North (J-TN) Study of Patients (Pts) With Moderately to Severely Active Ulcerative Colitis (UC)
Year: 2025
Source: ECCO'25
Authors: Zhangx7x7x7 J.(1);Gilvaryx7x7x7 C.(2);Schwarzx7x7x7 J.(2);Uchikawax7x7x7 Y.(3);Fujimotox7x7x7 G.(4);Zhangx7x7x7 C.(3);Harrisx7x7x7 S.(1)*;
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0692: Comparing JAK inhibitors in ulcerative colitis: which one truly leads in the real world? Results from the ENEIDA registry of GETECCU
Year: 2025
Source: ECCO'25
Authors: Chaparrox7x7x7 M.(1)*;Hermidax7x7x7 S.(1);Camargo Camerox7x7x7 R.(2);Ripoll Abadíax7x7x7 P.(3);Vela-Gonzálezx7x7x7 M.(4);Casanovax7x7x7 M.J.(1);de Castrox7x7x7 L.(5);Gargallo-Puyuelox7x7x7 C.J.(6);Arias Garcíax7x7x7 L.(7);de Franciscox7x7x7 R.(8);Zabalza San Martínx7x7x7 L.(9);Barreiro-de Acostax7x7x7 M.(10);Tosca Cuquerellax7x7x7 J.(11);Rodríguez Lagox7x7x7 I.(12);Calvo Moyax7x7x7 M.(13);Larrubia Domínguezx7x7x7 C.(14);Pajares Villarroyax7x7x7 R.(15);Robledo Andrésx7x7x7 P.(16);Calafatx7x7x7 M.(17);Gutiérrezx7x7x7 A.(18);Martínez Pascualx7x7x7 C.(19);Sanjosé Crespox7x7x7 A.(20);Caballolx7x7x7 B.(21);Sierra-Ausínx7x7x7 M.(22);Castro Poceirox7x7x7 J.(23);Giordanox7x7x7 A.(24); Huguetx7x7x7 J.M.(25); Mejías Manzanox7x7x7 M.Á.(26);Reygosa Castrox7x7x7 C.(27);Ruiz-Cerullax7x7x7 A.(28);Almelax7x7x7 P.(29); Trapero Martínezx7x7x7 A.M.(30);Castro Senosiainx7x7x7 B.(31);Iglesias Floresx7x7x7 E.(32);Martín-Rodríguezx7x7x7 D.(33);Varela Trastoyx7x7x7 P.(34);Ceballosx7x7x7 D.(35); Diz-Lois Palomaresx7x7x7 M.T.(36); Domènechx7x7x7 E.(17);Gisbertx7x7x7 J.P.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0693: The Chicago Mesenteric Fat Index: A Novel Biomarker for Assessing Inflammation in Pediatric Crohn’s Disease with Point of Care Intestinal Ultrasound
Year: 2025
Source: ECCO'25
Authors: Kellar x7x7x7 A.(1);George x7x7x7 T.(1);Dolinger x7x7x7 M.(2)*;Smyth x7x7x7 M.(3);Krugliak-Cleveland x7x7x7 N.(4);Rubin x7x7x7 D.(5);St-Pierre x7x7x7 J.(6);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0694: Clinical response trajectories identify distinct subpopulations of ulcerative colitis patients and are linked to disease outcome across different therapy classes. Patient level analysis of 2378 participants from 6 randomized controlled trials in moderate-severe UC representing 8 different mechanisms of action.
Year: 2025
Source: ECCO'25
Authors: Schreiberx7x7x7 S.W.(1)*;Mueller-Breckenridgex7x7x7 A.(2);Chengx7x7x7 J.(3);Wux7x7x7 C.(4);Jelinskyx7x7x7 S.A.(5);Liux7x7x7 J.(6);Agueusopx7x7x7 I.(7);Freitag-Wolfx7x7x7 S.(8);Hallx7x7x7 A.(9);Baribaudx7x7x7 F.(10);El Houjajjix7x7x7 C.(2);Paunx7x7x7 A.(2);McBridex7x7x7 J.(11);Braniganx7x7x7 P.(6);Hartx7x7x7 A.(6);Waterworthx7x7x7 D.(6);Galex7x7x7 J.(5);Woolcottx7x7x7 J.C.(5);Flechsenharx7x7x7 K.(7);Rawlingsx7x7x7 C.A.(7);Candelax7x7x7 N.(3);Yajnikx7x7x7 V.(3);Krawczakx7x7x7 M.(8);Thakkerx7x7x7 P.(3);Hechtx7x7x7 P.(7);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session